Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 29, 2025, BeyondSpring (BYSI) has a market cap of $64.103 million USD. According to our data, BeyondSpring is ranked No.7944 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 29, 2025 | $64.10 M |
-2.42%
|
| Dec 31, 2024 | $65.69 M |
81.11%
|
| Dec 29, 2023 | $36.27 M |
-52.13%
|
| Dec 30, 2022 | $75.76 M |
-58.50%
|
| Dec 31, 2021 | $0.18 B |
-62.87%
|
| Dec 31, 2020 | $0.49 B |
-21.29%
|
| Dec 31, 2019 | $0.62 B |
-17.33%
|
| Dec 31, 2018 | $0.76 B |
-35.52%
|
| Dec 29, 2017 | $1.17 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$152.20 B |
0.126 B
|
USA
|
 Gilead Sciences
GILD
|
$132.39 B |
-0.001 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$98.62 B |
0.002 M
|
USA
|
 Merck
MRK
|
$212.01 B |
-0.001 M
|
USA
|
 Pfizer
PFE
|
$130.73 B |
-0.001 M
|
USA
|
 Novartis
NVS
|
$225.97 B |
0.161 B
|
Switzerland
|
 Johnson & Johnson
JNJ
|
$375.44 B |
0.012 M
|
USA
|
 Eli Lilly
LLY
|
$797.31 B |
0.011 M
|
USA
|
 AstraZeneca
AZN
|
$221.12 B |
0.008 M
|
UK
|
 Sanofi
SNY
|
$128.86 B |
0.003 M
|
France
|
 GlaxoSmithKline
GSK
|
$77.05 B |
0.003 M
|
UK
|
 Regeneron Pharmaceuticals
REGN
|
$66.78 B |
1.110 B
|
USA
|
 Biogen
BIIB
|
$17.44 B |
-0.001 M
|
USA
|
| Market Cap | = | BYSI Stock Price | * | BYSI Shares Outstanding |
| = | $1.59 | * | 40.32 M | |
| = | $64.10 M |